A Phase I & II Open-label Study of the Effects of Anakinra (Kineret) in Corticosteroid-resistant Subjects With Sudden Sensorineural Heaing Loss (SSNHL)
Phase of Trial: Phase I/II
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Sensorineural hearing loss
- Focus Therapeutic Use
- 07 Dec 2016 Status changed from completed to discontinued.
- 08 Sep 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 14 Apr 2015 New trial record